These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8184257)

  • 1. Lymphokine-activated killer cells induce differentiation in MCF-7 breast carcinoma nodules but not in mastosis nodules maintained in three-dimensional culture.
    Gharib M; Mainguené C; Tamboise E; Tamboise A; Beaupain R
    Tumour Biol; 1994; 15(2):90-100. PubMed ID: 8184257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of lymphokine-activated killer cells and A549 lung carcinoma nodules maintained in three-dimensional culture.
    Gharib M; Tamboise E; Tamboise A; Lièvre N; Vérola O; Beaupain R
    Tumour Biol; 1997; 18(3):135-45. PubMed ID: 9143410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of LAK cells activated by IL-2 on MCF-7 human breast cancer cell line maintained in organotypic culture].
    Gharib M; Mainguené C; Tamboise E; Tamboise A; Lièvre N; Amouroux J; Beaupain R
    Bull Cancer; 1993 Aug; 80(8):659-65. PubMed ID: 8204946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lymphokine-activated killer-cells on melanoma nodules maintained in 3-dimensional culture.
    Gharib M; Tamboise E; Tamboise A; Lievre N; Verola O; Beaupain R
    Int J Oncol; 1995 Dec; 7(6):1327-32. PubMed ID: 21552968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [LAK sensitivity of human pancreas carcinoma cell lines].
    Sugiura H
    Hokkaido Igaku Zasshi; 1993 Nov; 68(6):921-34. PubMed ID: 7906667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy.
    Streck RJ; Helinski EH; Ovak GM; Pauly JL
    J Leukoc Biol; 1990 Sep; 48(3):237-46. PubMed ID: 2391448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting effects of cancer sera on in vitro responses of peripheral blood lymphocytes to recombinant interleukin-2.
    Komatsu F
    Bull Tokyo Med Dent Univ; 1989 Dec; 36(4):69-74. PubMed ID: 2632134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infiltrative and cytolytic activities of lymphokine-activated killer (LAK) cells against a human glioma mass: ultrastructural analysis using a three-dimensional multicellular spheroid model].
    Iwasaki K
    Nihon Geka Hokan; 1990 Jan; 59(1):39-54. PubMed ID: 2130768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
    Alderson MR; Sassenfeld HM; Widmer MB
    J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
    Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
    Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lymphokine-activated killer cell induction by human recombinant IL-1 receptor antagonist. Obligate paracrine pathway of IL-1 during lymphokine-activated killer cell induction.
    Fujiwara T; Grimm EA
    J Immunol; 1992 May; 148(9):2941-6. PubMed ID: 1374105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactions between interleukin-4, interleukin-2, and tumor necrosis factor-alpha for lymphokine-activated killer cell generation.
    Blay JY; Branellec D; Robinet E; Gay F; Chouaib S
    J Clin Lab Anal; 1990; 4(1):54-8. PubMed ID: 2313467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
    Abe Y; Van Eden M; Gatanaga M; Wang FI; Brightbill HD; Granger GA; Gatanaga T
    Lymphokine Cytokine Res; 1993 Oct; 12(5):279-83. PubMed ID: 8260536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ; Merchant RE; Hall RE
    Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of cytolytic activity and cell surface phenotypes of lymphokine activated killer cells stimulated with R-IL 2 and an anti-CD 3 antibody].
    Kikuchi T; Sakai H; Nakamura N; Watanabe M; Ohno T
    No To Shinkei; 1990 Jun; 42(6):575-80. PubMed ID: 2119634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro.
    Higuchi CM; Thompson JA; Lindgren CG; Gillis S; Widmer MB; Kern DE; Fefer A
    Cancer Res; 1989 Dec; 49(23):6487-92. PubMed ID: 2479463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes.
    Lamers HJ; Gratama JW; van Putten WL; Stoter G; Bolhuis RL
    Cancer Res; 1991 May; 51(9):2324-8. PubMed ID: 2015597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological observation of human LAK cell killing activity on lung adenocarcinoma cells].
    Xu ZY
    Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):425-8. PubMed ID: 2076637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
    Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S
    Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.